Novavax opens Phase 3 trial for COVID-19 vaccine candidate

preview_player
Показать описание
Another vaccine candidate is taking a step forward. Novavax announced Monday it is starting a phase three trial for its vaccine candidate in the United States and Mexico. Tampa will host a site for the clinical trial.
Рекомендации по теме